Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.

Abstract

Changes in mRNA expression of soluble NSF-attachment protein receptors (SNAREs) and SNARE-associated proteins have been shown to occur in a number of disorders such as schizophrenia, Alzheimer's disease and Parkinson's disease. We have shown previously that there is a decrease in protein levels of the SNARE-associated protein, complexin II (CPLXII) in Huntington's disease brain and in the R6/2 mouse model of Huntington's disease. In the current study, we used quantitative in situ hybridisation to examine mRNA expression of SNAREs (25 kDa synaptosome-associated protein (SNAP-25), syntaxin-1A and synaptobrevin-2) and SNARE-associated proteins (alpha-SNAP, CPLXI and CPLXII) in brain of R6/2 mice and their wild type littermates between 3 and 15 weeks of age. We found an early and progressive decrease of CPLXII expression in R6/2 mice brains. In contrast, no changes in SNARE expression were seen in R6/2 brains compared with wild type brain. Further, while decreased expression of alpha-SNAP and CPLXI was seen, this was not until 15 weeks of age and even then the changes were small. We suggest that downregulation of expression of mRNA encoding SNARE-associated proteins, first CPLXII and later CPLXI and alpha-SNAP, contributes to the progressive neuropathology of the R6/2 mouse model of Huntington's disease.

Statistics

02040'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

73 Citations

Semantic Scholar estimates that this publication has 73 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Freeman2004RegionalAP, title={Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.}, author={Whitney Freeman and A. Jennifer Morton}, journal={Brain research bulletin}, year={2004}, volume={63 1}, pages={45-55} }